Clinical Trial Update: Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for adults with relapsed or refractory multiple myeloma sponsored by Nerviano Medical Sciences. The study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Nerviano Medical Sciences | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED